Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor Study.
Danielle Novetsky FriedmanPamela J GoodmanWendy M LeisenringLisa R DillerSusan L CohnRebecca M HowellSusan A SmithEmily S TonorezosSuzanne L WoldenJoseph P NegliaKristen K NessTodd M GibsonPaul C NathanBrent R WeilLeslie L RobisonKevin C OeffingerGregory T ArmstrongCharles A SklarTara O HendersonPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Neuroblastoma survivors treated during infancy have a relatively low absolute burden of late mortality and SMN. Encouragingly, risk of CHCs has declined in more recent eras with reduced exposure to radiation therapy.